Biotherapeutics Group, National Institute for Biological Standards and Control, Potters Bar, UK.
Vox Sang. 2013 Feb;104(2):153-8. doi: 10.1111/j.1423-0410.2012.01647.x. Epub 2012 Sep 23.
Testing for neutrophil antibodies has become more common as awareness of transfusion-related acute lung injury (TRALI) has increased. However, unlike other areas of blood cell antibody testing, there are no certified reference reagents available with which laboratories can determine the sensitivity of detection of their assays. This report describes the production and evaluation of a freeze-dried preparation of human plasma, code 09/284, containing anti-human neutrophil antigen-1a (anti-HNA-1a) for use as a minimum sensitivity reagent.
One-millilitre of aliquots of plasma containing anti-HNA-1a were freeze-dried in glass ampoules. To characterize the material, 24 laboratories took part in an international collaborative study. The participants evaluated doubling dilutions of the material using their in-house routine assays and recorded the highest dilution in which the antibody could be detected.
When diluted 1 in 4, most laboratories were able to detect the anti-HNA-1a in the material, and the participants agreed that this was an appropriate level to set as the minimum sensitivity required.
In October 2011, the WHO Expert Committee on Biological Standardization approved the material 09/284 as an International Reference Reagent for the detection of anti-HNA-1a.
随着对输血相关性急性肺损伤(TRALI)认识的提高,对中性粒细胞抗体的检测变得越来越普遍。然而,与其他血细胞抗体检测领域不同,目前没有可用的认证参考试剂来确定实验室检测其检测方法的灵敏度。本报告描述了一种冻干制剂的制备和评估,该制剂是人血浆,代码为 09/284,含有抗人中性粒细胞抗原-1a(抗-HNA-1a),用作最低灵敏度试剂。
将含有抗-HNA-1a 的 1 毫升等分试样在玻璃安瓿中冻干。为了对该材料进行特征描述,有 24 个实验室参与了国际协作研究。参与者使用内部常规检测方法评估了该材料的两倍稀释度,并记录了可以检测到抗体的最高稀释度。
当稀释至 1/4 时,大多数实验室能够检测到该材料中的抗-HNA-1a,参与者一致认为这是设定最低灵敏度所需的适当水平。
2011 年 10 月,世界卫生组织生物标准化专家委员会批准该材料 09/284 作为检测抗-HNA-1a 的国际参考试剂。